In recent years we are witnessing an increase in thoracic pathology thanks to the increase in lung cancer screening, we have also observed an increase in complex cases of chest wall pathology. Lung cancer screening can lead to overdiagnosis and over-treatment as a result of increased awareness of lung cancer with a more intensive screening and the identification of a larger number of lung nodules with low, medium or high risk of malignancy. This should be an opportunity to optimize the application of the best treatment for patients at risk of lung cancer.
The standardization has meant a very important advance in the improvement of outcomes of the thoracic surgery procedures. It may seem contradictory, therefore, to focus the aim of precision on the management of specific individuals, but precision surgery is a step forward, once standardization is achieved, for most of the procedures used in thoracic surgery, thanks to the greater precision. It is necessary to pay particular attention to individual elements so that the treatments become more effective, we are able to apply a surgery of maximum precision taking into account the individual characteristics of the patients, and this without prejudicing the improvement generated by the standardization of the surgical processes.
In this Focused Issue of the PCM journal about Precision Surgery for Lung Cancer, we gather some contributions in the most innovative aspects of thoracic surgery treatment, from the patient-tailored prevention of post-operative complications after lung resection to the planning, identification and precision marking of the lesions for subsequent approach, as well as how to improve the precision of closed chest sublobar resections. And also the demonstrated effectiveness of the precision of robotic surgery for the treatment of lung cancer or the application of 3D printing technologies for modelling the reconstruction of the chest wall, as a result of collaboration with engineers specialized in biomechanics. Especially relevant is the training in minimally invasive pulmonary resections as a way to increase the accuracy of these procedures. We are confident that the impact of these innovations in the treatment and management of patients with lung cancer or chest wall tumors will result in an improvement in the health and wellness of treated patients.
Provenance and Peer Review: This article was commissioned by the editorial office, Precision Cancer Medicine for the series “Precision Surgery for Lung Cancer”. The article did not undergo external peer review.
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/pcm.2019.11.01). The series “Precision Surgery for Lung Cancer” was commissioned by the editorial office without any funding or sponsorship. MJ served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Precision Cancer Medicine from Aug 2018 to Jul 2020. The author has no other conflicts of interest to declare.
Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
Cite this article as: Jimenez M. Precision surgery, it matters. Precis Cancer Med 2019;2:37.